Clinical Role - Hospital

Pharmacy Times® is at the forefront of providing the latest clinical updates, patient counseling tools and innovative solutions to hospital pharmacists and reaches more than 200,000 pharmacy professionals in total.

Novartis and Rising Pharmaceuticals are donating doses of hydroxychloroquine to be utilized by researchers investigating safety and efficacy against COVID-19.
New advances in medical therapy have made it possible for rosacea patients to achieve clear skin.
The prevalence of HIV in jails and prisons is approximately 4 times higher than that of the general United States population.
According to the researchers, the case fatality rate for patients with COVID-19 and cardiovascular disease is 10.5%.
Small cell lung cancer is highly aggressive and fast-growing, typically recurring and progressing rapidly despite the initial response to chemotherapy.
During the COVID-19 pandemic, pharmacists are concerned not only about shortages in drugs that could treat the virus, but also medications for managing other conditions.
A highlighted session from the ASHP 54th Midyear Clinical Meeting, held December 8-12, 2019, in Las Vegas, Nevada.
What are the advantages and disadvantages of linezolid versus daptomycin for vancomycin-resistant enterococcus bacteremia?
What should covered entities do to prepare for increased reporting requirements?
Curtis E. Haas, PharmD, FCCP, editor-in-chief of Pharmacy Times: Directions in Health-System Pharmacy, and chief pharmacy officer for the University of Rochester’s health care system, discusses preparation for potential patient surge due to COVID-19.
Recent estimates indicate that less than 10% of patients who are at risk for acquiring HIV are prescribed PrEP.
Ed Cohen, PharmD, FAPhA, executive vice president of pharmacy advocacy for the publication, was recognized with the prestigious Individual Advocate of the Year award.